Eucalyptin is a natural product found in eucalyptus species. It has shown antimicrobial and insecticidal activity, making it a promising candidate for pharmaceutical and agricultural applications. Research on eucalyptin focuses on understanding its biosynthesis, identifying its specific targets, and optimizing its production for potential use in drug development and pest control.'
eucalyptin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 76573 |
| CHEMBL ID | 4750729 |
| SCHEMBL ID | 1250942 |
| MeSH ID | M0409030 |
| Synonym |
|---|
| 5-hydroxy-4',7-dimethoxy-6,8-dimethylflavone |
| 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-6,8-dimethyl-4-benzopyrone |
| einecs 221-502-8 |
| eucalyptin |
| 3122-88-1 |
| LMPK12111028 |
| 4',7-dimethoxy-6,8-dimethyl-5-hydroxyflavone |
| 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-6,8-dimethylchromen-4-one |
| AKOS016009468 |
| FT-0634682 |
| SCHEMBL1250942 |
| 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-6,8-dimethyl-4h-chromen-4-one |
| 5-hydroxy-7,4'-dimethoxy-6,8-dimethylflavone |
| DTXSID60185145 |
| FS-9743 |
| 4',7-dimethoxy-6,8-dimethyl-5-hydroxyflavone; eucalyptin |
| flavone, 5-hydroxy-4',7-dimethoxy-6,8-dimethyl- |
| B0005-178920 |
| A876000 |
| CHEMBL4750729 |
| HY-N3876 |
| CS-0024388 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1696140 | Anticancer activity against human PANC-1 cells assessed as reduction in cell viability in nutrient-deprived medium after 24 hrs by WST-8 assay | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||